We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$227M
AUM Growth
-$55.7M
Cap. Flow
-$8.71M
Cap. Flow %
-3.85%
Top 10 Hldgs %
50.08%
Holding
105
New
12
Increased
23
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
+$2.18M
2
ARGX icon
argenx
ARGX
+$1.58M
3
ALT icon
Altimmune
ALT
+$1.14M
4
AAPL icon
Apple
AAPL
+$1.1M
5
XNCR icon
Xencor
XNCR
+$1.08M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.93M
2
KIN
Kindred Biosciences, Inc.
KIN
+$3.32M
3
ORCL icon
Oracle
ORCL
+$1.99M
4
GLD icon
SPDR Gold Trust
GLD
+$1.67M
5
AMD icon
Advanced Micro Devices
AMD
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 39.04%
2 Miscellaneous 27.83%
3 Technology 12.14%
4 Communication Services 8.72%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AYX
101
DELISTED
Alteryx Inc
AYX
– –
-5,000
Closed -$430K
OBSV
102
DELISTED
ObsEva SA Ordinary Shares
OBSV
– –
-26,500
Closed -$80K
SPFR.WS
103
DELISTED
Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl
SPFR.WS
– –
-30,000
Closed -$58K
KIN
104
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-362,315
Closed -$3.32M
ALXN
105
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-6,000
Closed -$1.1M
1 2 3 4
5

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, DCF Advisers held 105 positions worth $227M, down 20% from $282M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers withdrew a net $8.71M in Q3 2021, closing 24 positions and reducing 19 holdings. Its most notable exit was Kindred Biosciences, Inc., an estimated $3.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, DCF Advisers opened a new position in Impel Pharmaceuticals Inc. Common Stock worth $1.83M.

  • DCF Advisers's largest Q3 2021 buy was Impel Pharmaceuticals Inc. Common Stock: 150,000 shares worth $1.83M.
  • DCF Advisers added most to argenx in Q3 2021, an estimated $1.58M increase.
  • DCF Advisers's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $5.93M.
  • DCF Advisers fully exited Kindred Biosciences, Inc. in Q3 2021, selling an estimated $3.32M.
  • DCF Advisers's ten largest holdings make up 50% of its $227M portfolio in Q3 2021.
  • DCF Advisers opened 12 new positions and closed 24 in Q3 2021.
  • DCF Advisers's portfolio value fell 20% quarter-over-quarter to $227M.

Based on DCF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.